2022年9月7日 · Low-level viremia (LLV): HIV-1 plasma viral load above the limit of quantification of clinical assays (20-50 copies/mL), usually between 20-500 copies/mL. Viral blip: an episode …

Here, we review the incidence, risk factors, and potential consequences of low-level HIV viremia (LLV; defined in this review as a viremia level of 50 to 500 copies/ml) and very-low-level …

All low-level viraemia ranges (51–199 copies per mL, 200–399 copies per mL, and 400–999 copies per mL) were associated with an increased risk of virological failure and non-suppression.

2021年8月13日 · People living with HIV (PLWH) and receiving antiretroviral therapy (ART) have a goal of achieving and maintaining viral suppression; however, low-level viraemia (LLV) (HIV …

This review summarizes various definitions of low-level viremia and related terms, as well as the current evidence on incidence, risk factors, and clinical outcomes of low-level viremia in …

2024年11月7日 · Current guidelines and primary literature for managing persons living with HIV who have persistently low levels of HIV RNA are scarce. Considering the risks associated with …

2023年11月26日 · Low-level viremia is defined as a persistent detectable HIV RNA level above the lower limit of detection of the assay (usually 20 to 50 copies/mL) but less than 200 …

The definitions of optimal viral suppression, low-level viremia, blips, virologic failure, and recommended management approaches to low-level viremia vary greatly across studies and …

Low level viremia (LLV), defined as two or more consecutive HIV-1 RNA ≥ 50 copies/mL, has an estimated prevalence of between 5% and 30% [6, 7]. Studies have varied in identifying the …

Studies have evaluated the impact of low-level viremia (LLV), often defined as consistently low but detectable VL (<1000 copies/mL), on the progression of HIV-1 infection.